Randomized Evaluation of COVID-19 Therapy
Condition:   Severe Acute Respiratory Syndrome Interventions:   Drug: Lopinavir-Ritonavir;   Drug: Corticosteroid;   Drug: Hydroxychloroquine;   Drug: Azithromycin;   Drug: Tocilizumab Sponsors:   University of Oxford;   UK Research and Innovation;   National Institute for Health Research, United Kingdom;   Wellcome;   Bill and Melinda Gates Foundation;   Department for International Development, United Kingdom;   Health Data Research UK;   Medical Research Council Popu lation Health Research Unit;   NIHR Clinical Trials Unit Support Funding Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 11, 2020 Category: Research Source Type: clinical trials

INOVIO Expands Manufacturing of COVID-19 DNA Vaccine INO-4800 With New Funding from CEPI
PLYMOUTH MEETING, Pa., April 30, 2020 /PRNewswire/ -- INOVIO (NASDAQ:INO) today announced it has entered into an agreement to expand its manufacturing partnership with the German contract manufacturer Richter-Helm BioLogics GmbH& Co. KG,... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 30, 2020 Category: Pharmaceuticals Source Type: clinical trials

Sensory Analysis and Taste Modulation of Ketone Esters
Condition:   Flavor Perception in Normal, Healthy Adults Intervention:   Other: Flavor additive Sponsors:   Monell Chemical Senses Center;   HVMN (funding; holder of primary Department of Defense STTR contract) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 2, 2020 Category: Research Source Type: clinical trials